J&J names executives to helm spin-off consumer health company


J&J said Wednesday it has named Thibaut Mongon as chief executive officer designate of the future consumer-health products company, which J&J plans to split off sometime in 2023.

Mr. Mongon, 52, has more than 20 years of experience at J&J and has served as executive vice president and world-wide chairman of the health-products company’s consumer business since 2019.

J&J also said Paul Ruh, who is the consumer unit’s chief financial officer, will take the same position with the new company. Mr. Ruh, 55, has been CFO of the unit since 2017, and before that served in finance roles at PepsiCo Inc.

J&J said it would name additional executives for the new consumer company in the coming months.

https://www.wsj.com/articles/j-j-names-executives-of-planned-tylenol-band-aid-company-11652265000